HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals.

Authors

Julia A Sung
Shabnum Patel
Matthew L Clohosey
Lauren Roesch
Tamara Tripic
JoAnn D Kuruc
Nancie Archin
Patrick J Hanley, George Washington University
C Russell Cruz, George Washington University
Nilu Goonetilleke
Joseph J Eron
Clio M Rooney
Cynthia L Gay
Catherine M Bollard, George Washington University
David M Margolis

Document Type

Journal Article

Publication Date

10-3-2018

Journal

Molecular therapy : the journal of the American Society of Gene Therapy

Volume

26

Issue

10

Inclusive Pages

2496-2506

DOI

10.1016/j.ymthe.2018.08.015

APA Citation

Sung, J., Patel, S., Clohosey, M., Roesch, L., Tripic, T., Kuruc, J., Archin, N., Hanley, P., Cruz, C., Goonetilleke, N., Eron, J., Rooney, C., Gay, C., Bollard, C., & Margolis, D. (2018). HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals.. Molecular therapy : the journal of the American Society of Gene Therapy, 26 (10). http://dx.doi.org/10.1016/j.ymthe.2018.08.015

Peer Reviewed

1